Related Experiment Video
Updated: Aug 19, 2026

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features
Ilia V Baskakov1, Olga V Bocharova
1Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore, Maryland 21201, USA. Baskakov@umbi.umd.edu
Abstract:
The "protein only" hypothesis of prion propagation postulates that the abnormal isoform of the prion protein, PrP(Sc), acts as a causative and transmissible agent of prion disease. In attempt to reconstitute prion infectivity in vitro, we previously developed a cell-free conversion protocol for generating amyloid fibrils from a recombinant prion protein encompassing residues 89-231 (rPrP 89-230) [Baskakov et al. (2002) J. Biol. Chem. 277, 21140]. When inoculated into transgenic mice, these amyloid fibrils induced prion disease, which can be efficiently transmitted to both wild-type and transgenic mice [Legname et al. (2004) Science 305, 673]. Here we show that the polymerization of rPrPs into the fibrils displays a number of distinctive kinetic features that are not typical for polymerization by other amyloidogenic polypeptides. Specifically, the lag phase of polymerization showed only modest dependence on protein concentration, and the conversion reaction displayed a dramatic volume-dependent threshold effect. To explain these unique kinetic features, we proposed that the conversion reaction is regulated by the dynamics between the rates of multiplication and deactivation of self-propagating fibrillar isoforms. Our further studies demonstrated that surface-dependent sorption of fibrillar isoforms is responsible for their deactivation in vitro, while fibril fragmentation seems to account for the multiplication of the active centers of polymerization. Our findings support the hypothesis that development of prion disease is controlled by a fine dynamic balance between self-propagation and clearance/deactivation of PrP(Sc).
Insights
Prion protein (PrP) polymerization kinetics differ from other amyloidogenic proteins, revealing a unique balance between self-propagation and deactivation crucial for prion disease development.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prion diseases are linked to the abnormal prion protein (PrPSc).
- Reconstituting prion infectivity in vitro is essential for studying disease mechanisms.
- Previous work generated infectious amyloid fibrils from recombinant PrP (rPrP).
Purpose of the Study:
- To investigate the unique kinetic features of rPrP polymerization into amyloid fibrils.
- To elucidate the mechanisms regulating prion conversion and propagation in vitro.
- To understand the dynamic balance governing prion disease development.
Main Methods:
- Cell-free conversion protocol using recombinant prion protein (rPrP 89-230).
- Kinetic analysis of rPrP polymerization, including lag phase and volume dependence.
- Investigating fibril deactivation (sorption) and multiplication (fragmentation) mechanisms.
Main Results:
- rPrP polymerization kinetics exhibit unusual features, including modest dependence on protein concentration and a volume-dependent threshold.
- Fibril deactivation is attributed to surface-dependent sorption.
- Fibril fragmentation appears to drive the multiplication of polymerization centers.
Conclusions:
- The polymerization of rPrP is regulated by the interplay between multiplication and deactivation rates of self-propagating fibrillar isoforms.
- Prion disease progression is influenced by the dynamic equilibrium between PrPSc self-propagation and its clearance or deactivation.
- These findings provide insights into the molecular mechanisms underlying prion propagation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

